2006
DOI: 10.1057/palgrave.jcb.3040170
|View full text |Cite
|
Sign up to set email alerts
|

Winning the game: Public funds for biotech companies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In dissecting these respondents’ workaround approaches, we see little novelty; indeed, several such workarounds were described decade ago in the classic politics of budgeting literature (e.g., Schick, 1969; Wildavsky, 1961, 1964). The strategy of writing specifications to fit sole source contracts has been pursued in a great many purchasing workarounds (Boudreau & Robey, 2005; Gollin et al, 2006) and often with the objective of achieving what many perceive to be as false efficiencies in procurement regulations (e.g., Ignatiadis & Nandhakumar, 2009; Michaels, 2010).…”
Section: Resultsmentioning
confidence: 99%
“…In dissecting these respondents’ workaround approaches, we see little novelty; indeed, several such workarounds were described decade ago in the classic politics of budgeting literature (e.g., Schick, 1969; Wildavsky, 1961, 1964). The strategy of writing specifications to fit sole source contracts has been pursued in a great many purchasing workarounds (Boudreau & Robey, 2005; Gollin et al, 2006) and often with the objective of achieving what many perceive to be as false efficiencies in procurement regulations (e.g., Ignatiadis & Nandhakumar, 2009; Michaels, 2010).…”
Section: Resultsmentioning
confidence: 99%